4 Major FDA Decisions Expected by June
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.
All Work
Chris Lange
Why Analysts Are Chasing Activision Blizzard Even Higher
When Activision Blizzard reported its most recent quarterly results, the company blew away its results, as it has done many times before, and now analysts are chasing this stock even higher.
Intellia Therapeutics Enters the Market With a Bang
Intellia Therapeutics entered the market with a bang on Friday, blowing out its expected price range of $16 to $18.
How Yelp Crushed Earnings Despite a Loss
Yelp reported better-than-expected first-quarter financial results after the markets closed on Thursday.
Cigna Slumps Despite Q1 Earnings Beat
Cigna reported mixed first-quarter financial results and offered guidance before the markets opened on Friday.
How Guidance Sank Endo International
Endo International reported mixed first-quarter financial results after the markets closed on Thursday.
GoPro Mixed Earnings Might Be Enough for Investors
GoPro, Inc. (NASDAQ: GPRO) reported first quarter financial results after the markets closed on Thursday. The company had a net loss of $0.63 per share on $183.5 million in revenue compared to consensus estimates…
FireEye vs. CyberArk: Who Won Earnings?
Both FireEye Inc. (NASDAQ: FEYE) and CyberArk Software Ltd. (NASDAQ: CYBR) reported first-quarter financial results after the markets closed on Thursday. 24/7 Wall Street took highlights from each of the earnings reports and put…
Is Pernix Therapeutics in a Race to Zero?
Pernix Therapeutics saw its shares hit a 52-week low in regular trading on Thursday after it reported its first-quarter financial results.
What to Look for in El Pollo Loco Earnings
El Pollo Loco Holdings is set to report its first-quarter financial results after the markets close on Thursday.
What to Expect From Activision Blizzard Earnings
Activision Blizzard is scheduled to release its most recent earnings report after the markets close on Thursday.
Oncobiologics Closes in on Market Entrance With Most Recent IPO Filing
Oncobiologics expects to price 5 million shares within the range of $11 to $13 per share in an initial public offering valued up to mroe than $74 million.
Can These 2 Cybersecurity Giants Turnaround the Industry With Earnings?
If FireEye and CyberArk Software lead the charge with solid earnings reports, we could expect to see a strong summer from the cybersecurity industry, similar to what we saw last year.
How Analysts View Priceline After Earnings
Priceline has been the center of attention recently following a sex scandal involving former CEO Darren Huston. The earnings report took the heat off a little, but questions remain about the overall direction of…
Is It Too Soon to Celebrate Zynga Earnings?
Zynga reported better-than-expected first-quarter financial results after the markets closed on Wednesday.
Why the AT&T Contract Is So Good for Synacor
Synacor watched its shares absolutely explode early on Thursday following a contract with a telecom giant. The company announced that AT&T.
3D Systems Rises Despite Top-Line Miss
3D Systems reported its first-quarter financial results before the markets opened on Thursday.
Whole Foods Finally Posts Solid Fiscal Q2
Whole Foods Market, Inc. (NASDAQ: WFM) reported fiscal second-quarter financial results after the markets closed on Wednesday. The company had $0.44 in earnings per share (EPS) on a record $3.7 billion in revenue compared to…
Why Fitbit Couldn’t Hurdle Q1 Earnings
Fitbit Inc. (NYSE: FIT) reported first-quarter financial results after the markets closed on Wednesday. The company had $0.10 in earnings per share (EPS) on $505.4 million in revenue compared to consensus estimates from Thomson…
SEC Charges Unregistered Brokers With Pocketing Money in Startup Scheme
The U.S. Securities and Exchange Commission recently charged two men with pocketing investor money.